Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer [Phase 1]
This Phase 1 clinical trial investigates a CCL21-gene modified dendritic cell vaccine in combination with pembrolizumab for stage IV non-sma…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M [Phase 2]
A Phase 2 trial comparing osimertinib plus bevacizumab versus osimertinib alone as second-line treatment in metastatic non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial update reports completion of a study evaluating an immunotherapy in combination with chemoradiation for advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer. [Phase 2]
Phase 2 study results evaluating the combination of ipilimumab and nivolumab in patients with anti-PD-1 therapy–resistant advanced non-small…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Universal Cancer Peptide-based Vaccination in Metastatic NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial of a universal cancer peptide-based vaccination for metastatic non-small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC [NA]
Completion of a clinical trial evaluating the NCCN decision support tool for patients with non-small cell lung cancer; results were posted o…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of DSP107 alone and in combination with atezolizumab. The study targets patients with a…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma [Phase 2]
This Phase 2 trial update reports the completion of a study evaluating atezolizumab, bevacizumab, and chemotherapy in EGFR-mutant stage IIIB…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 study evaluating durvalumab given with chemoradiation in patients with unresectable non-small cell lung cancer. Results were posted …
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC [Phase 2]
A Phase 2 trial comparing radical surgical resection with ablative stereotactic radiotherapy for operable stage I non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation [Phase 1]
Phase 1 study evaluating ABN401 for safety, pharmacokinetics, pharmacodynamics, and antitumor activity in advanced solid tumors and non-smal…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: 68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
This clinical trial evaluates the radiotracer 68Ga-grazytracer PET/CT for early assessment of response to neoadjuvant immunotherapy in resec…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy [Phase 2]
A Phase 2 study evaluating sargramostim plus pembrolizumab with or without pemetrexed in advanced non-small cell lung cancer after chemoimmu…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6) [Phase 2]
Phase 2 trial of Sunvozertinib (DZD9008) in pretreated non-small cell lung cancer patients with EGFR Exon 20 insertion; the study Wu-Kong6 i…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation [Phase 2]
A Phase 2 trial of TY-9591 in non-small cell lung cancer with EGFR activating mutation and brain or leptomeningeal metastases has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating how itraconazole or rifampicin affect TY-9591 tablets in healthy subjects.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC [Phase 2]
Phase 2 clinical trial update evaluating TY-9591 in combination with chemotherapy as first-line treatment for EGFR-mutated non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. [Phase 3]
A Phase 3 trial evaluating AL2846 capsule in combination with TQB2450 injection versus docetaxel in advanced non-small cell lung cancer pati…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma
This non-interventional real-world study assesses afatinib as first-line therapy and subsequent treatments in patients with advanced EGFR mu…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Real-World Immuno-Radiotherapy for Advanced NSCLC
A real-world trial update on immuno-radiotherapy for advanced non-small cell lung cancer, with the study status reported as completed.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral AMXT 1501 Dicaprate in Combination With IV DFMO [Phase 1, Phase 2]
A Phase 1/2 trial of oral AMXT 1501 dicaprate in combination with IV DFMO has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 study assessing safety, tolerability, and preliminary efficacy of CJRB-101 in combination with pembrolizumab in selected advanced …
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating durvalumab after chemoradiation and as consolidation therapy for stage III non-small cell lung cancer was termina…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India [Phase 4]
Phase 4 clinical trial update evaluating lorlatinib in ALK inhibitor-treated unresectable advanced or recurrent ALK-positive non-small cell …